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Introduction
The Burkholderia genus includes more than 60 species 
that colonize a wide range of environments including soil, 
water, plants, animal, and human (Mahenthiralingam et al. 
2008). They are well known for their nutritional versatility, 
which certainly contributes to their capacity to live in 
extreme and diverse habitats and which has led to their 
use in biocontrol, bioremediation processes, and biodeg-
radation of pollutants (Mahenthiralingam and Goldberg 
2005). Some Burkholderia species are involved in promoting 
plant or nitrogen- fixing bacteria (Caballero- Mellado et al. 
2007). On the other hand, several species of Burkholderia, 
including those from B. cepacia complex group (Bcc) as 
well as B. gladioli and B. fungorum, represent a significant 
threat to the life of immunocompromised individuals, 
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Abstract
Burkholderia is an important genus encompassing a variety of species, including 
pathogenic strains as well as strains that promote plant growth. We have carried 
out a global strategy, which combined two complementary approaches. The first 
one is genome guided with deep analysis of genome sequences and the second 
one is assay guided with experiments to support the predictions obtained in 
silico. This efficient screening for new secondary metabolites, performed on 48 
gapless genomes of Burkholderia species, revealed a total of 161 clusters contain-
ing nonribosomal peptide synthetases (NRPSs), with the potential to synthesize 
at least 11 novel products. Most of them are siderophores or lipopeptides, two 
classes of products with potential application in biocontrol. The strategy led to 
the identification, for the first time, of the cluster for cepaciachelin biosynthesis 
in the genome of Burkholderia ambifaria AMMD and a cluster corresponding 
to a new malleobactin- like siderophore, called phymabactin, was identified in 
Burkholderia phymatum STM815 genome. In both cases, the siderophore was 
produced when the strain was grown in iron- limited conditions. Elsewhere, the 
cluster for the antifungal burkholdin was detected in the genome of B. ambifaria 
AMMD and also Burkholderia sp. KJ006. Burkholderia pseudomallei strains harbor 
the genetic potential to produce a novel lipopeptide called burkhomycin, con-
taining a peptidyl moiety of 12 monomers. A mixture of lipopeptides produced 
by Burkholderia rhizoxinica lowered the surface tension of the supernatant from 
70 to 27 mN·m−1. The production of nonribosomal secondary metabolites seems 
related to the three phylogenetic groups obtained from 16S rRNA sequences. 
Moreover, the genome- mining approach gave new insights into the nonribosomal 
synthesis exemplified by the identification of dual C/E domains in lipopeptide 
NRPSs, up to now essentially found in Pseudomonas strains.
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especially for those who are suffering from cystic fibrosis 
or chronic granulomatous diseases (Coenye et al. 2001). 
Burkholderia pseudomallei and Burkholderia mallei are the 
only known members of the genus Burkholderia that are 
primary pathogens in humans and animals, causing meli-
oidosis in humans (Cheng and Currie 2005) and glanders 
in horses (Nierman et al. 2004). The ability to adapt and 
colonize a wide variety of environments is likely due to 
an unusually large, complex, and variable genome 
(4.6–9 Mb), split into up to three chromosomes and large 
plasmids. Furthermore, some species have been found to 
secrete a variety of extracellular enzymes with proteolytic, 
lipolytic, and hemolytic activities (Vial et al. 2007), together 
with secondary metabolites. These include siderophores 
called ornibactins and malleobactins (Franke et al. 2014), 
hemolytic peptides called cepalysins (Abe and Nakazawa 
1994), antifungal agents as pyrrolnitrin (Hammer et al. 
1999), cepapafungins, and related compounds cepacidines 
A1 and A2 (Lim et al. 1994). More recently, antifungal 
cyclic lipopeptides (CLPs) called occidiofungins/burkholdi-
nes (bks) have been isolated from strains belonging to 
the Bcc group (Gu et al. 2009; Tawfik et al. 2010). Some 
secondary metabolites including siderophores and lipopep-
tides can be produced nonribosomally by NonRibosomal 
Peptide Synthetases called NRPS (Marahiel 2009). These 
large synthetases are organized into sets of domains that 
constitute modules containing the information needed to 
complete an elongation step in an original peptide bio-
synthesis. The main catalytic functions are responsible for 
the activation of an amino acid residue (adenylation, - A 
domain), the transfer of the corresponding adenylate to 
the enzyme- bound 4- phosphopantetheinyl cofactor (thiola-
tion, - T domain), the peptide bond formation (condensa-
tion, - C domain), and the release of the peptide from 
the NRPS (thioesterase, - Te domain). Optional domains 
of NRPS modules can modify the amino acids by different 
reactions such as N- methylation, epimerization (- E domain), 
or heterocyclization.
A genome mining was conducted with the aim of iden-
tifying biosynthetic clusters for secondary metabolites, but 
in this study, we have chosen to only present the clusters 
including at least one gene encoding NRPS. The domain 
organization of each NRPS protein was designed, the 
C- domain sub- types were determined, and the prediction 
of the most probable produced peptides was performed 
in silico using specific bioinformatics tools included in the 
Florine workflow previously described (Caradec et al. 2014). 
We specially describe the identification of siderophores and 
lipopeptides because of their possible use in biocontrol 
(Sharma and Johri 2003; Roongsawang et al. 2011). Many 
of the structure and activity predictions obtained in silico 
are corroborated by experimental supports as biological 
activities from wild- type strains and deletion mutants, iron 
chelating measurements, surface tension, or MS detections 
of the compounds in growth supernatants.
Materials and Methods
In silico detection of NRPS genes within 
sequenced genomes
Forty- eight gapless complete genomes of Burkholderia 
strains available in the NCBI were mined by following 
the strategy described within the Florine workflow (Caradec 
et al. 2014). Sequences presenting identity with known 
NRPSs were detected by using the NCBI- Blastp tool with 
the B. cepacia GG4 OrbJ used as a query (YP_006615894). 
The automatically annotated proteins were also fished 
using a list of keywords including adenylation, synthetase, 
thiotemplate, phosphopantetheine, nonribosomal, NRPS, 
siderophores, ornibactin, pyochelin, syringomycin, malleo-
bactin, polyketide, and acyl carrier protein (ACP). 
Identification and annotation of NRPS gene clusters in 
all selected strains were also detected by antiSMASH (http://
antismash.secondarymetabolites.org) (Weber et al. 2015).
Protein sequences of all genes encoding NRPSs were 
obtained from NCBI databases. The modular organization 
and domain architecture were deciphered combining the 
results from NRPS- PKS analysis website (http://nrps.igs.
umaryland.edu/nrps) (Bachmann and Ravel 2009) and 
Structure- Based Sequence Analysis of Polyketide Synthases 
(SBSPKS) (http://www.nii.ac.in/~pksdb/sbspks/search_
main_pks_nrps.html) (Anand et al. 2010) with antiSMASH 
results. The specificity of the A domain was conducted 
by using the web- based software NRPSpredictor2 (http://
nrps.informatik.uni-tuebingen.de) (Röttig et al. 2011). The 
C- domain types were determined by identification of spe-
cific signatures of the DownSeq (Caradec et al. 2014). 
The D- configuration of monomers of nonribosomal peptide 
was predicted regarding the presence of E followed by 
DCL domains or dual C/E- domains.
The structures of the predicted peptides were compared 
to other nonribosomal peptides through the structural 
search tool of the Norine database (bioinfo.lifl.fr/norine) 
(Caboche et al. 2008, 2009).
Culture conditions and media
Strains, plasmids, and primers used in this study are listed 
in Table S1. Molds (Fusarium oxysporum, Galactomyces 
geotrichum, Botrytis cinerea, and Rhizoctonia solani) were 
gown on PDA (Sigma- Aldrich, St Louis, MO). Burkholderia 
strains, Micrococcus luteus, Listeria innocua, and Escherichia 
coli were routinely grown at 37°C on Luria Bertani (LB) 
medium. Candida albicans was grown on Sabouraud agar 
at 37°C and Saccharomyces cerevisiae was grown on 
514 © 2016 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. 
Q. Esmaeel et al.Burkholderia Genome Mining for NRPs
yeast- extract–peptone–dextrose at 30°C. For lipopeptide 
production, strains were grown in Landy medium buffered 
with MOPS 100 mmol/L (Landy et al. 1948). When 
required, gentamycin sulfate (Sigma Aldricht) was added 
at a concentration of 25 μg mL−1 for E. coli and at 
300 μg mL−1 for B. ambifaria AMMD wt and mutant 
strains.
Construction of AMMD mutant strains
Burkholderia ambifaria AMMD- Δbamb_6472 was con-
structed using in vivo homologous recombination in the 
yeast, S. cerevisiae InvSc1 (Shanks et al. 2006). To construct 
B. ambifaria AMMD- Δbamb_6472, two regions of the 
NRPS gene Bamb_6472 were amplified using primers 
Up6472- F and Up6472- R (1015 bp amplicon) and primers 
Down6472- F and Down6472- R (887 bp amplicon), respec-
tively. Deletion of NRPS gene Bamb_6472 was confirmed 
by PCR (See Protocole S2 for details).
Biological activity assays
Antifungal activity
Antifungal activity was demonstrated by contact antago-
nism assay. PDA plates were inoculated with 5 mm of 
agar plug of F. oxysporum, G. geotrichum, B. cinerea, and 
R. solani grown for 2 days on PDA. The plates were 
inoculated with the bacterium and incubated at 25°C for 
5–7 days.
Antiyeast activity
Antiyeast activity was performed by the agar drop plate 
method. Erlenmeyer flask containing 100 mL of PDB were 
inoculated with 1.5 mL of bacterial suspension containing 
about 108 CFU mL−1 and incubated under rotary shaking 
(160 rpm) at 37°C for 5 days. Then, the culture was 
centrifuged at 10,000g for 10 min at 4°C. The supernatant 
was concentrated 10 times via speed vacuum, and then 
50 μL of this supernatant were deposited on 14 mL solid 
Sabouraud medium inoculated with target strains includ-
ing C. albicans and S. cerevisiae. After 24 h of incubation 
at 30°C, the activity was estimated by measuring the 
diameter of the zone of inhibition of target strains.
Hemolytic activity
The hemolytic activity was assessed at 30°C on LB sup-
plemented with 5% (vol/vol) horse blood. Supernatant 
(50 μL) were spotted on the plates that were incubated 
for 48 h at 30°C. Positive results were detected by the 
formation of a clear zone around the wells.
MALDI- ToF mass spectrometry
Bacterial sample were cultured in liquid medium and 
 incubated at 37°C for 5 days. Supernatant was mixed with 
a matrix solution (10 mg/mL cyano- 4- hydroxycinnamic 
acid in 70% water, 30% acetonitrile, and 0.1% TFA). The 
samples were homogeneized on a Vortex and centrifuged 
at 4500 g. For classical analysis 1 μL of sample solution 
was spotted onto a MALDI- ToF MTP 384 target plate 
(Bruker Daltonik GmbH, Leipzig, Germany) according to 
the procedure of the dried- droplet preparation. Mass pro-
files experiments were analyzed with an Ultraflex MALDI- 
ToF/ToF mass spectrometer (Bruker, Bremen, Germany) 
equipped with a smartbeam laser. Samples were analyzed 
using an accelerating voltage of 25 kV and matrix sup-
pression in deflexion mode at m/z 750. The laser power 
was set to just above the threshold of ionization (around 
35%). Spectra were acquired in reflector positive mode 
in the range of 400 at 3000 Da. Each spectrum was the 
result of 2000 laser shots per m/z segment per sample 
delivered in 10 sets of 50 shots distributed in three dif-
ferent locations on the surface of the matrix spot. The 
instrument was externally calibrated in positive reflector 
mode using bradykinin [M+H]+ 757.3991, angiotensin II 
[M+H]+ 1046.5418, angiotensin I [M+H]+ 1296.6848, 
substance P [M+H]+ 1347.7354, bombesin [M+H]+ 
1619.8223, and ACTH (1- 17) [M+H]+ 2093.0862.
Production of siderophores
Strains were propagated three times in iron- deficient mini-
mum medium (MM9) (Payne 1994) supplemented with 
10% of casamino acids previously treated, first with 3% 
8- hydroxyquinoline in chloroform to remove contaminat-
ing iron and then with chloroform to remove remaining 
8- hydroxyquinoline. Then, MgCl2 1 mmol/L and CaCl2 
0.1 mmol/L were added. All glassware was rinsed with 
HCl 6 mol/L. CAS (Chrome Azurol S) liquid and agar 
assays were performed in accordance to the original pro-
tocol (Schwyn and Neilands 1987).
Surface tension measurements
The surface tension was measured according to the De 
Nouy methodology using a tensiometer TD1 (Lauda, 
Königshofen, Germany) as previously described (Leclère 
et al. 2006).
Phylogeny tree
The 16S rRNA sequences were extracted from RDP data-
base (Cole et al. 2009) and submitted to MEGA6 program 
(Tamura et al. 2013). The tree was built using the neighbor- 
joining method (Saitou and Nei 1987). The evolutionary 
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distances were computed using the maximum composite 
likelihood method (Tamura et al. 2004). The rate varia-
tion among sites was modeled with a gamma distribution 
with five rate categories. Bootstrap analysis with 1000 
replicates was performed to assess the support of the 
clusters (Felsenstein 1985). All positions containing gaps 
and missing data were eliminated. Cupriavidus taiwanensis 
was used as an outgroup reference.
Results
Overview on Burkholderia sequenced 
genomes
Forty- eight gapless complete genomes of Burkholderia 
strains available in 2014 within the NCBI genome bank 
were mined for NRPSs. To evaluate the relevancy of 
sequenced strains among the Burkholderia genus, the 16S 
rRNA sequences were extracted and aligned to build a 
phylogenetic tree of all sequenced strains (Fig. 1). The 
considered strains for NRPS seeking are representative of 
the genus as they include species playing ecological role 
related to xenobiosis, biocontrol, promotion of plant 
growth, biological nitrogen fixation, as well as pathogenic 
strains for animals as some of those belonging to the 
Bcc group. Elsewhere, the tree clearly shows that the strains 
are distributed into three clades. The first clade (clade I) 
includes B. mallei, B. pseudomallei, and the rarely patho-
genic B. thailandensis strains, the second clade (clade II) 
gathers the Bcc group strains. The remaining species are 
contained in the clade III.
All the strains have their genome split into up to three 
chromosomes added with one or two plasmids, exception-
ally three (B. sp.YI23), four (B. gladioli BSR3 and B. glumae 
BGR1), or five (B. vietnamiensis G4). The whole genome 
sizes span from 3.75 to 9.73 Mb with most frequent values 
between 7 and 9 Mb (33 strains).
Except for B. phenoliruptrix BR3459a and B. sp. 
CCGE1002, genes for at least one NRPS could have been 
detected in the genomic sequence of the 48 studied strains, 
whatever their lifestyle or virulence ability (Table 1).
Identification of a novel malleobactin- like 
siderophore
A cluster of genes including those for NRPS responsible 
for ornibactin or malleobactin synthesis has been found 
in the genome of 41 strains (Table 1) (Fig. 2A). The 
cluster is present on the larger chromosome (chromosome 
1), except for B. phytofirmans PsJN and B. xenovorans 
LB400 where it is located on chromosome 2, and for B. 
sp. YI23 and B. sp. RPE64 harboring the cluster on a 
plasmid. A complete cluster includes genes responsible for 
siderophore biosynthesis (coding for 2 NRPSs and acces-
sory enzymes modifying the monomers of the peptidic 
chain), genes implicated in the uptake (siderophore export 
and ferri- siderophore TonB dependent receptor) and the 
orbS or mbaF genes coding for an extracytoplasmic sigma70 
factor implicated in the regulation (Table S2). The NRPSs 
responsible for the siderophore backbone are encoded by 
orbI- orbJ and mbaA- mbaB in the case of ornibactin and 
malleobactin synthesis, respectively. The proteins harbor 
the same domain organization including 4 adenylation 
domains (A1- A4). The specificity code for the A1 domain 
is variable: Leu for ornibactin and Bht (beta- hydroxy- 
tyrosin) for malleobactin (Fig. 2A). According to the pres-
ence of an acyl transferase gene (orbL) together with the 
Leu selectivity of A1 domain, ornibactin is predicted to 
be produced by all the strains belonging to the Bcc group 
(B. ambifaria, B. cenocepia, B. cepacia, B. lata, B. multi-
vorans, B. vietnamiensis and B. sp. KJ006) and two strains 
belonging to the clade III (YI23 and RPE64). The malleo-
bactin synthetic cluster detected with the presence of an 
accessory enzyme gene (mbaM) and the Bht selectivity 
for A1 is found in the genomes of two strains belonging 
to the clade III (B. phytofirmans PsJN and B. xenovorans 
LB400), and the strains from clade I, except B. thailan-
densis 2002721723.
Burkholderia phymatum STM815 belonging to clade III, 
possesses on chromosome 2, a cluster with some char-
acteristics for malleobactin synthesis and uptake (absence 
of the acyl transferase gene orbL), together with features 
related to ornibactin biosynthesis (absence of mbaM and 
presence of orbK). Moreover, the predicted specificities 
of A1 and A4 domains of the NRPS are Asp and Cys, 
respectively. These predictions are different from those 
obtained both with ornibactin and malleobactin NRPS 
A1 and A4 domains (Fig. 2A). The strain B. phymatum 
STM815 was grown under iron- limited conditions and 
was analyzed for siderophore production. The CAS agar 
assay was positive showing an orange halo surrounding 
the strain (Fig. S1) and compounds with a mass comprised 
between 445 Da and 773 Da were detected and fragmented 
from supernatant. No fragmentation spectrum could have 
been assigned to a known siderophore belonging to orni-
bactin or malleobactin family. We suggest to name this 
probably new malleobactin- like siderophore phymabactin 
and the corresponding nrps genes phmA and phmB (Fig. 2) 
(Table S2).
Identification of a cluster involved in 
cepaciachelin synthesis
Pyochelin synthetase is constituted of two NRPSs of about 
1360 and 1890 AA, harboring a specific domain architec-
ture that includes two cyclization domains (Cy), associated 
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with two stand- alone proteins containing a Te and an A 
domain, respectively (Fig. 2B) (Michel et al. 2007; Gasser 
et al. 2015). Corresponding clustered genes have been 
found in the chromosome 2 of 19 and 5 strains belonging 
to clades I and II, respectively (B. lata ASM1294v1, all 
B. cenocepia, B. pseudomallei and B. thailandensis strains 
except B. thailandensis MSMB121) (Table 1). Except for 
B. thailandensis 2002721723 for which no malleobactin 
synthesis genes have been found, pyochelin synthesis clus-
ters are always present together with ornibactin or 
Figure 1. Phylogenetic tree of the Bukholderia strains with complete genome sequenced. Performed using MEGA6 (Tamura et al. 2013), the tree 
was built using the neighbor-joining method (Saitou and Nei 1987). The bootstrap analysis (Felsenstein 1985) with 1000 replicates was performed 
to assess the support of the clusters. The analysis involved 48 16S rRNA sequences and all positions containing gaps and missing data were 
eliminated. ▲Clade I, Clade II, Clade III, colored symbols representing the different clusters are presented in front of each strain.
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malleobactin synthesis genes. No relationship between 
occurrence of the pyochelin cluster and the belonging to 
the clade I or II can be established.
In the chromosome 1 of B. ambifaria AMMD, a second 
cluster characteristic of a siderophore synthesis pathway 
has been identified beside the cluster for ornibactin syn-
thesis. This cluster includes a gene for a TonB- dependent 
receptor, genes to build up a diOH- bz (2,3- dihydroxy 
benzoic acid) monomer and two nrps genes coding for a 
complex constituted of one stand- alone A domain and a 
protein with a [Cstarter- A- Te] domain architecture 
(Fig. 2B). The specificity code for the isolated A domain 
is diOH- bz monomer with a score of 90%. The specificity 
code for the second A domain is Lys. The organization 
of the genes and the predictions associated to both A 
domains are highly compatible with the cepaciachelin 
siderophore synthesis. The strain was grown under iron- 
limited conditions allowing the production of siderophores 
(Fig. S1A). Mass spectrometry analysis of the supernatant 
revealed the coproduction of two compounds with masses 
corresponding to C4- ornibactin ([M + H+] + Fe = 759; 
[M + Na+] + Fe = 787) and cepaciachelin ([M + H+] = 
789; [M + Na+] = 511) (Fig. S1B). The fragmentation 
of the latter compounds revealed the presence of diOH- bz 
and putrescine residues. The production of both sidero-
phores (ornibactin and cepaciachelin) was totally abolished 
by addition of iron into the culture broth (not shown).
Identification of a novel lipopeptide 
synthetase containing dual C/E domains
A complete cluster corresponding to a lipopeptide synthesis 
pathway has been found in chromosome 2 in the genomes 
of 9/15 strains belonging to the pseudomallei species 
(Table 1) (Fig. 3). The NRPS is generally constituted of 
three proteins containing three, four, and five modules, 
respectively, except for strains 1106b, 1710a, and NCTC13179 
for which the mis- annotated synthetase spans on six, four, 
and five proteins, respectively. The NRPSs are generally 
annotated as “hypothetical protein,” “(non ribosomal) pep-
tide synthetase,” or “syringomycin synthetase.” The syn-
thetase composed of 12 [C- A- T] modules is predicted to 
produce a lipopeptide containing 12 monomers in the 
peptidic moiety. The first C domain has been identified 
as a Cstarter and the C domains of modules 2, 4, 6, 8, 
and 11 harbor the dual C/E signature found in CLP domains 
of Pseudomonas. This putative CLP12 is predicted to be 
FA_D- Ser_Glu_D- Ser_Arg_D- Thr_Leu_D- Dab_Thr_
Thr_D- Glu_Gly_Val (where FA is for Fatty Acid and Dab 
for diaminobutyric acid). Structure search query performed 
in the Norine database revealed no peptide displaying 
similar pattern, even when lowering the threshold to six 
monomers on the 12 of the peptidic moiety. We suggest 
to call this potential lipopeptide burkhomycin and to name 
the corresponding NRPSs BkmA, BkmB, and BkmC (Fig. 3).
The cluster was only partially found in the genome of 
the six remaining B. pseudomallei strains (MSRH 305, 
511, 520, NAU20B- 16, 668 and NCTC 13178) and in the 
genomes of two B. mallei strains (ATCC 23344 and NCTC 
10229) (Fig. 3).
All these NRPSs are characterized by the presence of 
a Cstarter, a Te tandem ending the assembly line, the lack 
of any E domain, and the presence of dual C/E domains. 
A gene encoding a protein of 927 AA, assumed to be an 
aminotransferase, is present within all the CLP biosynthetic 
clusters.
Lipopeptide production by B. glumae, 
B. gladioli, and B. rhizoxinica
Burkholderia glumae BGR1 and B. gladioli BSR3, both have 
a cluster of genes encoding a NRPS potentially producing 
a lipoheptapeptide (Table 1). Indeed, this protein can be 
divided into seven modules, the module 1 includes a 
Cstarter and modules 2, 3, 4, and 6 contain a dual C/E 
domain. For B. gladioli BSR3, the predicted peptidic moiety 
is D- Thr_D- Pro_D- Gln_Gly_D- X_Phe_Pro, where X rep-
resents a position for which no reliable prediction was 
obtained. For B. glumae BGR1, the same structure was 
predicted except that a D- Ser is predicted for position 3.
The higher number of NRPS gene clusters was found 
in B. rhizoxinica HKI454. The genome of this strain is 
constituted of one chromosome and two large plasmids 
pBRH01 and pBRH02, containing 2949, 784, and 203 
genes, respectively. The genome mining using the key-
word “nonribosomal” revealed at least 31 potentially 
interesting genes, 12 located on the chromosome and 
19 on the plasmid pBRH01. The NRPS clusters represent 
4% of the total genome length. We have further analyzed 
the 19 proteins with a size larger than 1000 AA and 
we also considered smaller proteins when they were 
supposed to be included in cluster also containing larger 
NRPSs. Finally, 13 clusters were pointed out, 10 of them 
being harbored by the plasmid pBRH01 (Table S3). All 
the NRPSs contain at least one dual C/E domain and 
nine of them start with a Cstarter domain, without any 
ambiguity. The synthetases are predicted to direct the 
synthesis of 13 different lipopeptides spanning from two 
to ten monomers within the peptidic moiety. For clusters 
10, 11, and 13, the synthetases contain additional meth-
ylation domains. The strain was grown in different media 
(LB, TSB, TSB- glycerol, nutrient broth, Landy). The 
production of compounds with surfactant properties was 
assessed by surface tension measurements. The com-
pounds produced by the strain grown in Landy medium 
displayed the higher activity lowering the surface tension 
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Table 1. Overview on NRPS identified by genome mining on Burkholderia strains.
Main siderophore Secondary siderophore Lipopeptides Antifungal Unknown products
Phylogenic 
group Burkholderia species
Genome 
size (Mb)
Number of 
chromosomes
Number of 
plasmids Lifestyle Ornibactin Malleobactin Pyochelin Cepaciachelin
Burkhomycin 
(CLP12) Cstart_Te (LP) Burkholdin
“630- 2979” 
AT- CATECAT
PKS- 3100_1300_ 
1500
PKS- NRPS 
“6274” NRPS
Clade I B. thailandensis MSMB121 6.73 2 0 Saprophytic, human 
pathogen (rare)
Chr1     
B. thailandensis H0587 6.76 2 0 Saprophytic, human 
pathogen (rare)
Chr1 Chr2 Chr1 Chr2    
B. thailandensis E264 6.72 2 0 Saprophytic, human 
pathogen (rare)
Chr1 Chr2 Chr1 Chr2   
B. thailandensis E444 6.65 2 0 Saprophytic, human 
pathogen (rare)
Chr1 Chr2 Chr1 Chr2   
B. thailandensis 2002721723 6.57 2 0 Saprophytic, human 
pathogen (rare)
 Chr2 Chr1 Chr2   
B. pseudomallei NCTC 13179 7.33 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2   
B. pseudomallei MSHR305 7.42 2 0 Human pathogen Chr1 Chr2 Chr2(11) Chr1 Chr2 Chr1  
B. pseudomallei MSHR520 7.45 2 0 Human pathogen Chr1 Chr2 Chr2(9) Chr1 Chr2 Chr1  
B. pseudomallei K96243 7.25 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei 1710a 7.33 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei 668 7.04 2 0 Human pathogen Chr1 Chr2 Chr2(5) Chr1 Chr2 Chr1  
B. pseudomallei 1710b 7.30 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei NAU20B- 16 7.31 2 0 Human pathogen Chr1 Chr2 Chr2(7) Chr1 Chr2   
B. pseudomallei 1106b 7.21 2 0 Human pathogen Chr1 Chr2 Chr2 (S) Chr1 Chr2 Chr1  
B. pseudomallei 1106a 7.08 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei 1026b 7.23 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei MSHR511 7.31 2 0 Human pathogen Chr1 Chr2 Chr2(10) Chr1 Chr2 Chr1(S)  
B. pseudomallei BPC006 7.15 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei MSHR146 7.31 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1(S)  
B. pseudomallei NCTC 13178 7.39 2 0 Human pathogen Chr1 Chr2 Chr2(10) Chr1 Chr2 Chr1  
B. mallei NCTC 10229 5.74 2 0 Human and animal 
pathogen
Chr1 Chr2(5) Chr1    
B. mallei SAVP1 5.23 2 0 Human and animal 
pathogen
Chr1 Chr1    
B. mallei NCTC 10247 5.84 2 0 Human and animal 
pathogen
Chr1    
B. mallei ATCC 23344 5.83 2 0 Human and animal 
pathogen
Chr1 Chr2(5)    
Clade II B. multivorans ATCC 17616 7.01 3 1 Human pathogen Chr1    
B. multivorans ATCC 17617 7.01 3 1 Human pathogen Chr1    
B. sp. KJ006 6.63 3 1 Biocontrol, mutualist Chr1 Chr3    
B. cepacia GG4 6.47 2 0 Bioremediation, 
human pathogen
Chr1    
B. cenocepacia HI2424 7.70 3 1 Human pathogen Chr1 Chr2    
B. cenocepacia AU 1054 7.28 3 0 Human pathogen Chr1 Chr2    
B. cenocepacia J2315 8.05 3 1 Human pathogen Chr1 Chr2 (P)    
B. cenocepacia MC0- 3 7.97 3 0 Plant pathogen, 
human pathogen
Chr1 Chr2    
B. lata ASM1294v1 8.68 3 0 Human pathogen Chr1 Chr2    
B. ambifaria AMMD 7.53 3 1 Biocontrol Chr1 Chr1 Chr3    
B. ambifaria MC40- 6 7.64 3 1 Human pathogen Chr1    
B. vietnamiensis G4 8.39 3 5 Mutualist, human 
pathogen
Chr1     
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Table 1. Overview on NRPS identified by genome mining on Burkholderia strains.
Main siderophore Secondary siderophore Lipopeptides Antifungal Unknown products
Phylogenic 
group Burkholderia species
Genome 
size (Mb)
Number of 
chromosomes
Number of 
plasmids Lifestyle Ornibactin Malleobactin Pyochelin Cepaciachelin
Burkhomycin 
(CLP12) Cstart_Te (LP) Burkholdin
“630- 2979” 
AT- CATECAT
PKS- 3100_1300_ 
1500
PKS- NRPS 
“6274” NRPS
Clade I B. thailandensis MSMB121 6.73 2 0 Saprophytic, human 
pathogen (rare)
Chr1     
B. thailandensis H0587 6.76 2 0 Saprophytic, human 
pathogen (rare)
Chr1 Chr2 Chr1 Chr2    
B. thailandensis E264 6.72 2 0 Saprophytic, human 
pathogen (rare)
Chr1 Chr2 Chr1 Chr2   
B. thailandensis E444 6.65 2 0 Saprophytic, human 
pathogen (rare)
Chr1 Chr2 Chr1 Chr2   
B. thailandensis 2002721723 6.57 2 0 Saprophytic, human 
pathogen (rare)
 Chr2 Chr1 Chr2   
B. pseudomallei NCTC 13179 7.33 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2   
B. pseudomallei MSHR305 7.42 2 0 Human pathogen Chr1 Chr2 Chr2(11) Chr1 Chr2 Chr1  
B. pseudomallei MSHR520 7.45 2 0 Human pathogen Chr1 Chr2 Chr2(9) Chr1 Chr2 Chr1  
B. pseudomallei K96243 7.25 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei 1710a 7.33 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei 668 7.04 2 0 Human pathogen Chr1 Chr2 Chr2(5) Chr1 Chr2 Chr1  
B. pseudomallei 1710b 7.30 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei NAU20B- 16 7.31 2 0 Human pathogen Chr1 Chr2 Chr2(7) Chr1 Chr2   
B. pseudomallei 1106b 7.21 2 0 Human pathogen Chr1 Chr2 Chr2 (S) Chr1 Chr2 Chr1  
B. pseudomallei 1106a 7.08 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei 1026b 7.23 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei MSHR511 7.31 2 0 Human pathogen Chr1 Chr2 Chr2(10) Chr1 Chr2 Chr1(S)  
B. pseudomallei BPC006 7.15 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1  
B. pseudomallei MSHR146 7.31 2 0 Human pathogen Chr1 Chr2 Chr2 Chr1 Chr2 Chr1(S)  
B. pseudomallei NCTC 13178 7.39 2 0 Human pathogen Chr1 Chr2 Chr2(10) Chr1 Chr2 Chr1  
B. mallei NCTC 10229 5.74 2 0 Human and animal 
pathogen
Chr1 Chr2(5) Chr1    
B. mallei SAVP1 5.23 2 0 Human and animal 
pathogen
Chr1 Chr1    
B. mallei NCTC 10247 5.84 2 0 Human and animal 
pathogen
Chr1    
B. mallei ATCC 23344 5.83 2 0 Human and animal 
pathogen
Chr1 Chr2(5)    
Clade II B. multivorans ATCC 17616 7.01 3 1 Human pathogen Chr1    
B. multivorans ATCC 17617 7.01 3 1 Human pathogen Chr1    
B. sp. KJ006 6.63 3 1 Biocontrol, mutualist Chr1 Chr3    
B. cepacia GG4 6.47 2 0 Bioremediation, 
human pathogen
Chr1    
B. cenocepacia HI2424 7.70 3 1 Human pathogen Chr1 Chr2    
B. cenocepacia AU 1054 7.28 3 0 Human pathogen Chr1 Chr2    
B. cenocepacia J2315 8.05 3 1 Human pathogen Chr1 Chr2 (P)    
B. cenocepacia MC0- 3 7.97 3 0 Plant pathogen, 
human pathogen
Chr1 Chr2    
B. lata ASM1294v1 8.68 3 0 Human pathogen Chr1 Chr2    
B. ambifaria AMMD 7.53 3 1 Biocontrol Chr1 Chr1 Chr3    
B. ambifaria MC40- 6 7.64 3 1 Human pathogen Chr1    
B. vietnamiensis G4 8.39 3 5 Mutualist, human 
pathogen
Chr1     
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Main siderophore Secondary siderophore Lipopeptides Antifungal Unknown products
Phylogenic 
group Burkholderia species
Genome 
size (Mb)
Number of 
chromosomes
Number of 
plasmids Lifestyle Ornibactin Malleobactin Pyochelin Cepaciachelin
Burkhomycin 
(CLP12) Cstart_Te (LP) Burkholdin
“630- 2979” 
AT- CATECAT
PKS- 3100_1300_ 
1500
PKS- NRPS 
“6274” NRPS
Clade III B. glumae BGR1 7.28 2 4 Plant pathogen Chr2 (LP7)   Chr2 (4a + 4b)
B. gladioli BSR3 9.05 2 4 Plant pathogen Chr2 (LP7 + LP5)  Chr1 Chr2 (4a + 4b)
B. xenovorans LB400 9.73 3 0 Mutualist Chr2
B. sp. CCGE1003 7.04 2 0 Mutualist Chr1
B. sp. CCGE1001 6.83 2 0 Mutualist Chr1
B. rhizoxinica HKI 454 3.75 1 2 Mutualist Chr1 +  plasmid 
(13 LPs)
B. sp. CCGE1002 7.88 3 1 Mutualist
B. phymatum STM815 8.68 2 2 Mutualist, nitrogen 
fixation
Chr2
B. sp. YI23 8.89 3 3 Bioremediator Plasmid Chr3(6) Chr3
B. phytofirmans PsJN 8.21 2 1 Biocontrol Chr2
B. sp. RPE64 6.96 3 2 Mutualist Plasmid
B. phenoliruptrix BR3459a 7.65 2 1 Mutualist
Potentially new forms are in italics. Chr, chromosome on which the cluster is; *numbers in brackets indicate the number of monomers expected in  
the product when different from the model; (P), partial cluster; (S), the NRPS is split into more proteins than in the model; LP, lipopeptide.  
*white box is for Chr1; light grey box is for Chr2; dark grey box is for Chr3
Table 1. (Continued)
Figure 2. Siderophore biosynthesis clusters. Clusters are presented on the left side and the products on the right side. Genes are represented by 
arrows colored as follows: green for NRPS, orange for accessory enzymes, red for regulatory proteins, blue for uptake participation, and pink for 
unknown function. Genes encoding TonB-dependent receptor are underlined. The domain organization of the NRPSs is shown below arrows. A, 
adenylation domain; Cst, C-starter; LCL, condensation between two l-monomers; 
DCL, condensation between d-monomer and l-monomer; Cy, 
heterocyclisation domain; E, epimerization domain; T, thiolation domain; Te, thioesterase domain; predicted amino acid specificity is shown under 
each A domain; Bht, beta–hydroxy-tyrosin; diOH-bz, 2, 3-dihydroxybenzoic acid; sal, salicylic acid. (A) Main siderophores. Genes and monomers 
specific for malleobactin or ornibactin synthesis are framed and highlighted by dotted squares, respectively. (B) Secondary siderophores.
(A)
(B)
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from 70 to 27 mN·m−1. Compared to results obtained 
with purified surfactin, the curve corresponding to sur-
face tension versus supernatant dilution clearly shows 
that a mixture of several active compounds is produced 
by B. rhizoxinica HK1454 (Fig. S2). The supernatant was 
then analyzed by MALDI- ToF. A group of peaks, char-
acteristic of lipopeptide detection with different fatty 
acid chain lengths, with mass differences of 14 Da (1522 
and 1536), was observed. (Fig. S2). The same supernatant 
was tested for antimicrobial activities. An antibacterial 
activity was observed against Micrococcus luteus and 
Listeria innocua. A moderate inhibition was observed 
against the yeast C. albicans ATCC10231, and no activity 
at all against fungi F. oxysporum, B. cinerea, and R solani 
(not shown).
Identification of the antifungal Bk cluster 
in the genomes of B. ambifaria AMMD 
and B. sp.KJ006
The genome mining revealed an nrps- containing cluster 
located in chromosome 3 of 2 strains: B. ambifaria AMMD 
and B. sp. KJ006. This large cluster spanning over 49 000 nt 
also includes genes coding for regulatory, decorating, and 
transporter proteins. The proteins exhibit several typical 
features of NRPS/PKS hybrids involved in Bk biosynthesis 
(Fig. 4). Eight modules are present, containing NRPS 
domains as C, A, E, T, and PKS domains as acetytrans-
ferase (AT), ACP, ketosynthetase (KS), and ketoreductase 
(KR) domains. The predicted compound can have the 
following structure Ile_PKM_Ser_D- Trp_D- Ser_Gly_
Asn_D- Ser where the PKM represent a monomer 
incorporated by the PKS domains. This predicted peptide 
looks like cyclic glycolipopeptides belonging to the bk/
occidiofungin family. Different types of condensation 
domains have been detected: LCL, 
DCL following an E 
domain, and an hybrid condensation domain (noted “C”) 
allowing the condensation of a PKM to an NRP monomer 
(Fig. 4). The presence of a gene encoding a glycosyl 
transferase suggests that the product can be 
glysosylated.
A large 9530- bp fragment within gene Bamb_6472 of 
B. ambifaria AMMD was deleted using in vivo homologous 
recombination in the yeast, S. cerevisiae InvSc1 leading 
to AMMD- Δbamb_6472 mutant (Protocole S2).
Both the AMMD wild type and mutant were tested 
for biological activities potentially related to the Bk pro-
duction. Compared to the AMMD wild- type strain, the 
AMMD- Δbamb_6472- deficient mutant failed to inhibit 
growth of C. albicans and S. cerevisiae, exhibited a reduced 
hemolytic activity, and antagonistic effect on F. oxysporum, 
G. geotrichum, B. cinerea, and R solani (Fig. S3). Culture 
supernatants from wild- type and deletion mutant both 
grown in LB broth at 37°C were analyzed by MALDI- 
ToF. Two peaks observed for m/z 1200.5 and 1222.65 
corresponding to the [M+H] and [M+Na] forms of a 
compound with a mass of 1999.5 Da were only detected 
in the wild- type supernatant (Protocole S2). Moreover, 
MALDI- ToF mass spectrometry analysis of culture super-
natants confirmed that the production of an antifungal 
compound with a mass of 1999.5 Da was completely 
abolished in AMMD- Δbamb_6472 mutant. Considering 
their belonging to the biosynthesis pathway for bk, the 
genes were named bks for Bk synthesis (Fig. 4).
Main siderophore Secondary siderophore Lipopeptides Antifungal Unknown products
Phylogenic 
group Burkholderia species
Genome 
size (Mb)
Number of 
chromosomes
Number of 
plasmids Lifestyle Ornibactin Malleobactin Pyochelin Cepaciachelin
Burkhomycin 
(CLP12) Cstart_Te (LP) Burkholdin
“630- 2979” 
AT- CATECAT
PKS- 3100_1300_ 
1500
PKS- NRPS 
“6274” NRPS
Clade III B. glumae BGR1 7.28 2 4 Plant pathogen Chr2 (LP7)   Chr2 (4a + 4b)
B. gladioli BSR3 9.05 2 4 Plant pathogen Chr2 (LP7 + LP5)  Chr1 Chr2 (4a + 4b)
B. xenovorans LB400 9.73 3 0 Mutualist Chr2
B. sp. CCGE1003 7.04 2 0 Mutualist Chr1
B. sp. CCGE1001 6.83 2 0 Mutualist Chr1
B. rhizoxinica HKI 454 3.75 1 2 Mutualist Chr1 +  plasmid 
(13 LPs)
B. sp. CCGE1002 7.88 3 1 Mutualist
B. phymatum STM815 8.68 2 2 Mutualist, nitrogen 
fixation
Chr2
B. sp. YI23 8.89 3 3 Bioremediator Plasmid Chr3(6) Chr3
B. phytofirmans PsJN 8.21 2 1 Biocontrol Chr2
B. sp. RPE64 6.96 3 2 Mutualist Plasmid
B. phenoliruptrix BR3459a 7.65 2 1 Mutualist
Potentially new forms are in italics. Chr, chromosome on which the cluster is; *numbers in brackets indicate the number of monomers expected in  
the product when different from the model; (P), partial cluster; (S), the NRPS is split into more proteins than in the model; LP, lipopeptide.  
*white box is for Chr1; light grey box is for Chr2; dark grey box is for Chr3
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Figure 4. Gene cluster responsible for burkholdin (Bk) biosynthesis in Burkholderia ambifaria AMMD. (A) all genes involved in Bk synthesis; gene 
numbers are above the arrows, annotations from NCBI are reported above the gene numbers. Different colors are used to distinguish between 
the functions: green is for modular enzymes, orange for accessory enzymes, blue for transport, red for regulation, and pink for hypothetical 
protein. (B) Modular organization of Bk synthesis proteins (Bks). ?, nonidentified domains; A, adenylation domain; C, hybrid condensation domain 
allowing condensation between a PKS monomer and an NRPS monomer; LCL, condensation between two l-monomers; 
DCL, condensation 
between d-monomer and l-monomer; T, thiolation domain; E, epimerization domain; Te, thioesterase domain; AT, acetytransferase domain; AC, 
acyl carrier protein domain; KS, ketosynthetase domain; KR, ketoreductase domain. Predicted amino acid specificity is shown under each A 
domain.
(A)
(B)
Figure 3. Burkhomycin biosynthesis gene clusters. Burkholderia pseudomallei 1710b is represented as a model for the complete cluster found in 
most strains. All the partial clusters are drawn below. Genes are represented by arrows, dotted lines are for lacking genomic sequences, lines 
represent the fusions in the proteins. Similar domains (adenylation with the same prediction and condensation with the same type) have been 
aligned. A, adenylation domain; C/E, dual condensation domain catalyzing both epimerization and condensation; LCL, condensation between two 
l-monomers; Cst, Cstarter for condensation between fatty acid and l-monomer; T, thiolation domain; Te, thioesterase domain.
523© 2016 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd. 
Burkholderia Genome Mining for NRPsQ. Esmaeel et al.
Discussion
The comprehensive mining carried out on genome 
sequences has revealed numerous clusters of genes involved 
in the synthesis of secondary metabolites including genes 
coding for PKS, NRPS, and hybrids. Among them, more 
than 160 clusters contain at least one nrps gene. With 
only two exceptions, such nrps containing clusters were 
found in all the explored genomes, whatever phylogenetic 
distance (Fig. 1) and the bacterial lifestyle (Table 1). 
Indeed, Burkholderia is an intriguing and important genus 
encompassing a variety of species and strains, ranging 
from highly pathogenic organisms to strains that promote 
plant growth (Mahenthiralingam et al. 2008). Some of 
these properties can be related to the production of sec-
ondary metabolites, especially NRPs as those displaying 
antifungal activities as Bks (Lin et al. 2012). In this article, 
we have focused on nonribosomal siderophores and lipo-
peptides because of their potential role in biocontrol, but 
the annotations we have assigned to some genes will also 
be very helpful to infer the “Burkholderia genome data-
base,” a specific tool dedicated to cystis fibrosis research 
community and aimed to facilitate comparative analysis 
(Winsor et al. 2008). Elsewhere, the present work com-
pletes previous analysis as the annotation of the genome 
of B. rhizoxinica HKI 454 (Lackner et al. 2011). Especially, 
with this example, we have shown the relevancy of com-
bining approaches both in silico and in wetlab.
The genomic mining for new NRPs highlighted the 
presence of clusters specific for strains belonging to clade 
I. This includes a cluster annotated “630- 2979” and two 
hybrid PKS- NRPS “3100- 1300- 1500” and “6274,” named 
according to the protein sizes (Table 1, Fig. 1). None of 
the three predicted peptides share any pattern with the 
known curated peptides annotated in the Norine database. 
We have no other clues leading to the prediction for 
siderophore activity or lipopeptide structure and the con-
cerned strains are pathogenic. We can guess that the 
products may be involved in the virulence and will not 
be useful in biocontrol, but this has to be further sup-
ported experimentally. Moreover, as they seemed to be 
only produced by bacteria belonging to clade I, they can 
be considered as maker of the pseudomallei species.
As expected, a cluster for biosynthesis of malleobactin 
and ornibactin was pointed out from the genomes of bac-
teria belonging to clade I and Bcc group, respectively (Franke 
et al. 2014, 2015). However, potentially new forms for a 
main siderophore have been identified in other strains. These 
includes a malleobactin- like produced by B. phymatum we 
have called phymabactin, and compounds putatively pro-
duced by B. sp. CCG1001 and B. sp. CCG1003. The latter 
NRPSs contain 6 and 7 modules allowing the production 
of compounds displaying no resemblance with already known 
peptides but the clusters are highly suspected to produce 
a siderophore synthetase because of the presence of genes 
coding for a TonB- dependent siderophore receptor and an 
MbtH domain- containing protein (Lautru et al. 2007).
As found in some Pseudomonas strains, a pyochelin 
synthesis cluster has been identified in the genome of 
strains also producing ornibactin or malleobactin. The 
cosynthesis of more than one siderophore by bacteria is 
not well understood, but it has been suggested that beside 
their ability to provide access to iron, pyochelin, whose 
affinity for iron is much lower (Cox et al. 1981), may 
have alternative roles including antibacterial activity 
(Cornelis and Matthijs 2002; Adler et al. 2012). The pyo-
chelin production may also be associated with the virulence 
of bacteria (Sokol and Woods 1988). Burkholderia ambi-
faria AMMD does not produce pyochelin, but we have 
found a cluster of eight genes, located on chromosome 
1, directing a siderophore synthesis. The identified cluster 
includes a gene for a TonB- dependent receptor, genes 
encoding enzymes necessary to build up a diOH- bz mono-
mer and two nrps genes, the predicted monomer for the 
first one being diOh- bz. All these elements evidenced for 
the relationship between the biosynthesis cluster and the 
cepaciachelin known to be produced B. ambifaria strain 
PHP7 (LMG 11351) (Barelmann et al. 1996). Indeed, 
although the structure of cepaciachelin has been known 
for a long time (Barelmann et al. 1996), the mechanism 
of its synthesis was not yet reported. This relationship 
between genes and the product was supported by MS 
detection, performed on culture supernatants of the strain 
grown under iron- limited conditions allowing the produc-
tion of siderophores (Fig. S1). As the cepciachelin is a 
nonribosomal peptide, the siderophore has been introduced 
into the Norine database, the id NOR01254 was 
attributed.
CLPs are versatile molecules composed of a fatty acid 
tail linked to a cyclic oligopeptide head, considered as 
efficient weapons for plant disease biocontrol (Ongena 
and Jacques 2008). Nearly all CLPs characterized to date 
have been identified from Pseudomonas and Bacillus spe-
cies (Roongsawang et al. 2011). This is comforted with 
the Norine querying indicating that 139 peptides belonging 
to 15 families are lipopeptides with surfactant activity. 
Among them, 76 are produced by Bacillus strains and 46 
by Pseudomonas strains and only 17 are produced by 
Serratia, Marinobacter, and Halomonas. With the genome 
mining of Burkholderia strains, we have found clusters 
of genes coding for NRPSs starting with Cstarter and 
ending with a tandem of Te domains, sharing these fea-
tures with NRPS of Pseudomonas CLPs (De Bruijn et al. 
2007). Furthermore, those NRPSs were lacking E domains, 
and some of the C domains were identified as dual C/E 
domains. These dual C/E domains were described for the 
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first time in the NRPS responsible for arthrofactin pro-
duction in Pseudomonas (Balibar et al. 2005). Since then, 
they have been detected in many NRPSs catalyzing the 
synthesis of CLPs in Pseudomonas (Roongsawang et al. 
2011) and more recently in Xanthomonas (Royer et al. 
2013). In all these cases, two types of NRPS clusters coex-
ist in the same strain. The first one contains E domains 
followed by DCL, generally directing the synthesis of a 
siderophore (i.e., pyoverdin), while the second type of 
NRPS containing dual C/E domains is involved in CLP 
synthesis. Strains can even synthesize several CLPs, with 
dual C/E domains for all the NRPSs (Pauwelyn et al. 
2013; D’aes et al. 2014). Thus, B. pseudomallei strains 
can produce malleobactin where an Asp residue is in 
D- configuration due to an E domain, and burkhomycin 
CLP, where five monomers can be epimerized by dual 
C/E domains. It is quite different with B. glumae, B. gladi-
oli, and B. rhizoxinica because no NRP harboring sidero-
phore activity has been identified. The co- occurrence of 
two distinct types of NRPs (with E domains vs. with 
dual C/E domains) in strains sharing the same soil habitat 
has to be further studied in terms of evolution, also con-
sidering the favored horizontal exchanges during the 
colonization of same ecological niches.
A total of 13 NRPS gene clusters were found in the 
plasmids (Burkholderia sp. I23, B. sp. RPE64, B. glumae 
BGR1, B.gladioli BSR3, and B. rhizoxinica HKI 454). Up 
to now, this singular feature had only been described in 
B. rhizoxinica (Lackner et al. 2011) and may be specific 
to the genus Burkholderia.
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Supporting Information
Additional supporting information may be found in the 
online version of this article:
Figure S1. Detection of siderophores by CAS assays and 
MALDI-ToF. Left: Burkholderia phymatum STM85, right: 
Burkholderia ambifaria AMMD. (A) CAS assays. The color 
change from blue to orange indicates the presence of 
iron- chelating compounds. (B) MALDI-ToF spectra. Peaks 
corresponding to cepaciachelin and ornibactin are pointed 
out by arrows.
Figure S2. Detection of lipopeptides produced by 
Burkholderia rhizoxinica HKI 454. The strain was grown 
in Landy medium. (A) Surface tension, (B) MALDI-ToF. 
A group of peaks were observed, characteristic of lipo-
peptide detection with different fatty acid chain lengths, 
with mass differences of 14 Da (1522 and 1536).
Figure S3. Biological activities of Burkholderia ambifaria 
AMMD. (A) antifungal activity. Burkholderia ambifaria 
AMMD was inoculated as a line in front of the fungal 
target on PDA medium. The fungi are mentioned under 
the plates. Plates were photographed 5 days after inocula-
tion. (B) Antiyeast activity. The yeasts are mentioned under 
the plates. 1: AMMD wild type, 2: ΔBamb_6472 mutant, 
3: sterile medium, 4: ethanol 70%. (C) Hemolytic activity 
on horse bood (5%) LB medium, 50 μL of supernatant 
obtained after 48 h of growth were used to fill the wells. 
1: AMMD wild type, 2: ΔBamb_6472 mutant.
Table S1. Strains, plasmids, and primers used in this study.
Table S2. Ornibactin, malleobactin, and phymabactin gene 
clusters. “+” and “−” mention the relative orientation of 
the genes. Numbers represent the size of the proteins (in 
AA). Colors represent the role of the protein in the sidero-
phore production: green for NRPS biosynthesis, orange 
for accessory enzymes, blue for uptake, red for regulation, 
and yellow for unknown function.
Table S3. NRPSs of Burkholderia rhizoxinica HKI 454. A, 
adenylation domain; LCL, condensation between two l- 
monomers; DCL, condensation between d- monomer and 
l- monomer; C/E, dual condensation domain catalyzing 
both epimerization and condensation; T, thiolation domain; 
E, epimerization domain; Te, Thioesterase domain; “?”, 
nonidentified domain; LP, lipopeptide.
Protocol S1. Construction of a B. ambifaria AMMD mutant 
deleted in burkholdin (Bk) synthesis. The supplementary 
file describes the construction of a mutant strain deleted 
in the gene bksG (Bamb_6472) to support the relationship 
between the cluster bks and the production of an antifungal 
compound belonging to Bk family.
